Powering Global Drug Development: Unlocking Japan & APAC’s Competitive Edge
Why Japan Should Be Part of Your Global Drug Development Strategy
As pharmaceutical and biotechnology companies look to expand their global clinical development strategies, Japan and the Asia-Pacific (APAC) region are emerging as increasingly valuable markets for clinical research, regulatory innovation, and commercial growth.
But what makes Japan an attractive destination for drug development, and why should sponsors consider entering the market earlier?
In this exclusive article developed by Citeline’s Scrip in association with CMIC Group, industry experts explore Japan’s evolving pharmaceutical landscape, recent regulatory reforms, and the strategic advantages of incorporating Japan into global clinical trials.
Featuring insights from leaders at CMIC, Alnylam Pharmaceuticals, the National Cancer Center Japan, and CBC Group/Jadeite Medicines, the article examines:
- Japan’s evolving regulatory landscape: How recent PMDA reforms are addressing drug lag and creating new opportunities for global pharmaceutical companies.
- Clinical trial advantages: Why Japan’s established clinical research infrastructure, high-quality data, and site management organizations (SMOs) make it a competitive destination for clinical development.
- Market access and commercial opportunities: How Japan’s pharmaceutical market, pricing frameworks, and patent protections can strengthen long-term development strategies.
- Expanding across APAC: How early engagement with Japan can support broader regulatory and market entry strategies throughout Asia-Pacific.
- Real-world industry perspectives: Practical insights from pharmaceutical and biotech leaders who have successfully navigated clinical development in Japan.
Is Japan the missing piece in your global drug development strategy?
Discover why early planning, local expertise, and a coordinated regional approach can help pharmaceutical and biotech companies unlock new opportunities in Japan and across APAC.
Download “Powering Global Drug Development: Unlocking Japan & APAC’s Competitive Edge” to explore the opportunities shaping the future of global drug development.
